Natco Pharma is planning to acquire significant stake in 135-year-old South African pharmaceutical giant Adcock Ingram. The South African Rand 4.2-billion deal will see Adcock Ingram becoming a privately-held entity co-owned by Natco and Bidvest, which will remain the majority shareholder in the group.
A meeting of shareholders of Adcock Ingram approved Natco's proposal to acquire all the ordinary shares in the company. Natco Pharma will acquire all the ordinary shares in Adcock Ingram through its subsidiary -- Natco Pharma South Africa.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: